Dapagliflozin Plus Metformin Versus Metformin Alone in Overweight and Obese Patients with Polycystic Ovary Syndrome - An Open-Label, Parallel, Randomized Controlled Trial.

Indian J Endocrinol Metab · 2026 · PMC13035301 · PMID 41918604

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Although greater decreases in WC, HC, and WHR were noted in the DAPA+MET group compared to the MET group, these differences did not reach statistical significance [ Table 2 ].

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.